Patent Assignment
Reel/Frame 073069/0550
Change of Name
Recorded: 2025-10-09
Pages: 4
Assignor
OCUPHIRE PHARMA, INC.
Executed: 2024-10-22
Assignee
OPUS GENETICS, INC.
8 DAVIS DRIVE, SUITE 220, DURHAM, NORTH CAROLINA, 27709
Covered Properties
(3)
Aqueous Ophthalmic Solutions of Phentolamine and Medical Uses Thereof
Application:
19/190,199 →
Publication:
US 2025/0248930
Aqueous Ophthalmic Solutions of Phentolamine and Medical Uses Thereof
Application:
19/190,234 →
Publication:
US 2025/0262149
Aqueous Ophthalmic Solutions of Phentolamine and Medical Uses Thereof
Application:
19/190,263 →
Publication:
US 2025/0248931
Related Assignments
(12)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Sep 5, 2025
From: MEYER, ALAN R.
To: OCULARIS PHARMA, LLC
Reel/Frame 072819/0118 →
Merger
Sep 5, 2025
From: OCULARIS PHARMA, LLC
To: OCUPHIRE PHARMA, INC.
Reel/Frame 072819/0123 →
Change of Name
Sep 5, 2025
From: OCUPHIRE PHARMA, INC.
To: OPUS GENETICS, INC.
Reel/Frame 072819/0127 →
Assignment of Assignor's Interest
Sep 5, 2025
From: MEYER, ALAN R.
To: OCULARIS PHARMA, LLC
Reel/Frame 072819/0162 →
Merger
Sep 5, 2025
From: OCULARIS PHARMA, LLC
To: OCUPHIRE PHARMA, INC.
Reel/Frame 072819/0167 →
Change of Name
Sep 5, 2025
From: OCUPHIRE PHARMA, INC.
To: OPUS GENETICS, INC.
Reel/Frame 072819/0171 →
Assignment of Assignor's Interest
Sep 5, 2025
From: MEYER, ALAN R.
To: OCULARIS PHARMA, LLC
Reel/Frame 072819/0136 →
Merger
Sep 5, 2025
From: OCULARIS PHARMA, LLC
To: OCUPHIRE PHARMA, INC.
Reel/Frame 072819/0141 →
Change of Name
Sep 5, 2025
From: OCUPHIRE PHARMA, INC.
To: OPUS GENETICS, INC.
Reel/Frame 072819/0155 →
Merger
Oct 9, 2025
From: OCULARIS PHARMA, LLC
To: OCUPHIRE PHARMA, INC.
Reel/Frame 073068/0845 →
Security Interest
Apr 21, 2026
From: OPUS GENETICS, INC.
To: OPCM SA LLC, AS PURCHASER AGENT FOR THE SECURED PARTIES
Reel/Frame 075478/0138 →
Assignment of Assignor's Interest
May 15, 2026
From: MEYER, ALAN R.
To: OCULARIS PHARMA, LLC
Reel/Frame 074673/0812 →